Heparin-induced circular dichroism of chloroquine

Biochemical and Biophysical Research Communications

Volumn 388, Issue 1, 2009, Pages 28-30

  Stanley, F E ^a   Warner, A M ^a   Gutierrez, S M ^a   Stalcup, A M ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Amyloid; Chloroquine; Chondroitin sulfate; Glycosaminoglycan; Heparin; Induced circular dichroism; Prion

Indexed keywords

CHLOROQUINE; GLYCOSAMINOGLYCAN; HEPARIN;

ARTICLE; CIRCULAR DICHROISM; ELECTRIC FIELD; OPTICAL ROTATION; PH MEASUREMENT; PRIORITY JOURNAL; ULTRAVIOLET SPECTROSCOPY;

CHLOROQUINE; CIRCULAR DICHROISM; GLUCOSAMINE; HEPARIN; HUMANS; PRION DISEASES; PRIONS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 68949163027     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.098     Document Type: Article

References (20)

1. Robinson H.C., Horner A.A., Hook M., Ogren S., and Lindahl U. A proteoglycan form of heparin and its degradation to single-chain molecules. J. Biol. Chem. 253 (1978) 6687-6693
2. Conrad H.E. Heparin-binding Proteins (1998), Academic Press, New York
3. Rabenstein D.L. Heparin and heparan sulfate: structure and function. Nat. Prod. Rep. 19 (2002) 312-331
4. Diaz-Nido J., Wandosell F., and Avila J. Glycosaminoglycans and β-amyloid, Prion and Tau peptides in neurodegenerative diseases. Peptides 23 (2002) 1323-1332
5. Pan T., Wong B.S., Liu T., Li R., Petersen R.B., and Sy M.S. Cell-surface prion protein interacts with glycosaminoglycans. Biochem. J. 368 (2002) 81-90
6. Prusiner S.B. Prions, Proc. Natl. Acad. Sci. 95 (1998) 13363-13383
7. Prusiner S.B. Molecular biology of prion diseases. Science 252 (1991) 1515-1522
8. Hill A.F., Zeidler M., Ironside J., et al. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349 (1997) 99-100
9. Heppner F.L., Musahl C., Arrighi I., Klein M.A., Rulicke T., Oesch B., Zinkernagel R.M., Kalinke U., and Aguzzi A. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294 (2001) 178-182
10. Priola S.A., Raines A., and Caughey W.S. Porphyrin and phthalocyanine anti-scrapie compounds. Science 287 (2000) 1503-1506
11. Sc incorporation to cells requires endogenous glycosaminoglycan expression. J. Biol. Chem. 280 (2005) 17057-17061
12. Castillo G.M., Lukito W., Wight T.N., and Snow A.D. The sulfate moieties of glycosaminoglycans are critical for the enhancement of β-amyloid protein fibril formation. J. Neurochem. 72 (1999) 1681-1687
13. Doh-Ura K., Iwaki T., and Caughey B. Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J. Virol. 74 (2000) 4894-4897
14. Korth C., May B.C., Cohen F.E., and Prusiner S.B. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc. Natl. Acad. Sci. 98 (2001) 9836-9841
15. Zsila F., and Gedeon G. Binding of anti-prion agents to glycosaminoglycans: evidence from electronic absorption and circular dichroism spectroscopy. Biochem. Biophys. Res. Commun. 346 (2006) 1267-1274
16. Zhang S., Zhao F., Li N., Li K., and Tong S. Spectroscopic studies on the spontaneous assembly of phenosafranin on glycosaminoglycans templates. Spectrochim. Acta A Mol. Biomol. Spectrosc. 58 (2002) 2613-2619
17. Salter M.K., Rippon W.B., and Abrahamson E.W. Spectroscopic properties of complexes of acridine orange with glycosaminoglycans. I. Soluble complexes. Biopolymers 15 (1976) 1213-1227
18. Stone A.L., and Moss H. Anomalous rotatory dispersion of metachromatic mucopolysaccharide-dye complexes. II. Heparin-methylene blue complexes at acidic pH. Biochim. Biophys. Acta 136 (1967) 56-66
19. Benesi H., and Hildebrand J. Spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons. J. Am. Chem. Soc. 71 (1949) 2703-2707
20. Stalcup A.M., and Agyei N.M. Heparin: a chiral mobile-phase additive for capillary zone electrophoresis. Anal. Chem. 66 (1994) 3054-3059